Allucent Awarded BARDA Contract to Support Acceleration of Next-Generation COVID-19 Booster Vaccines
CARY, N.C., August 28, 2023 – Allucent, a global mid-sized clinical research organization (CRO), announced that it has been selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services to accelerate clinical research and development for next-generation COVID-19 vaccine […]
Allucent Selects THREAD To Power Patient Direct Trials Offering
Biopharmaceutical Services Provider Allucent Partners with THREAD to Address Modern Clinical Trial Needs of Small and Emerging Biotech Companies CARY, N.C., June 20, 2023 – Global biopharmaceutical services provider Allucent announced on May 23, 2023 that it has partnered with THREAD, an innovative DCT and eCOA technology provider, to launch Allucent Patient Direct Trials. The new offering brings […]
Allucent Launches Decentralized Clinical Trial Solution at 2023 World Orphan Drug Congress
Biopharmaceutical Services Provider Allucent Partners with THREAD to Address Modern Clinical Trial Needs of Small and Emerging Biotech Companies News Summary CARY, N.C., May 23, 2023 – Global biopharmaceutical services provider Allucent announced today that it has partnered with THREAD, an innovative DCT and eCOA technology provider, to launch Allucent Patient Direct Trials. The new […]
Allucent Appoints Alexander J. MacDonald as Vice President of Model-Informed Drug Development
MARCH 14, 2023 CARY, N.C. – Global biopharmaceutical services leader, Allucent, announced today the appointment of Alexander J. MacDonald, Ph.D., M.Sc. as vice president of model-informed drug development (MIDD). In this important role, Dr. MacDonald will oversee the development and delivery of quantitative pharmacology using model-based solutions for Allucent’s partners in order to inform strategic decision-making […]
Allucent Appoints Life Science Veteran, Bob Millham, to Head Newly Formed Customer Engagement Unit
FEBRUARY 27, 2023 Cary, NC – Allucent is pleased to announce the appointment of Bob Millham to Global Head of Customer Engagement. Bob has been serving as Allucent’s President of Clinical Trial Operations since 2021, and as a 30-year veteran of the pharmaceutical industry brings vast experience and an impressive skill set to his new role. […]
Allucent Appoints Lisa Benincosa as Senior Vice President of Clinical Pharmacology Strategy
FEBRUARY 13, 2023 CARY, N.C., February 13, 2023 – Global biopharmaceutical services leader, Allucent, announced today the appointment of Lisa Benincosa, Ph.D., B.Pharm, as senior vice president of clinical pharmacology strategy. In this critical role, Benincosa will lead Allucent’s clinical pharmacology team in providing integrated drug development strategies to help Allucent’s partners optimize decision-making and create efficiencies […]
Allucent Is Now Great Place To Work Certified
JANUARY 24, 2023 January 2023 – Allucent has been Great Place To Work® Certified™ in India (from January 2023 to January 2024)! As a global authority on workplace culture, Great Place To Work® identifies exceptional workplaces that are characterized by great leadership, consistent employee experience, and sustainable financial performance. These organizations can deliver a consistent […]
Allucent Appoints Alexander Berg as Vice President of Clinical Pharmacology Development and Operations
JANUARY 10, 2023 CARY, N.C., January 10, 2023 – Global biopharmaceutical services leader, Allucent, announced today the appointment of Alexander (Al) Berg, Pharm.D., Ph.D., FCP, as vice president of clinical pharmacology development and operations. In this important role, Dr. Berg will help guide strategy, drive business opportunities, and lead operations across Allucent’s Clinical Pharmacology, Model Informed Drug Development (MIDD), […]